AU2004274694A1 - Nanoparticle conjugates and method of production thereof - Google Patents

Nanoparticle conjugates and method of production thereof Download PDF

Info

Publication number
AU2004274694A1
AU2004274694A1 AU2004274694A AU2004274694A AU2004274694A1 AU 2004274694 A1 AU2004274694 A1 AU 2004274694A1 AU 2004274694 A AU2004274694 A AU 2004274694A AU 2004274694 A AU2004274694 A AU 2004274694A AU 2004274694 A1 AU2004274694 A1 AU 2004274694A1
Authority
AU
Australia
Prior art keywords
nanoparticle
peptide
nanoparticles
nanoparticle conjugate
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004274694A
Other languages
English (en)
Inventor
Richard Christopher Doty
David Garth Fernig
Raphael Levy
John Arthur Smith
Dguyen Thi Kim Thanh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Publication of AU2004274694A1 publication Critical patent/AU2004274694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Peptides Or Proteins (AREA)
AU2004274694A 2003-09-19 2004-09-20 Nanoparticle conjugates and method of production thereof Abandoned AU2004274694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0321937.5 2003-09-19
GBGB0321937.5A GB0321937D0 (en) 2003-09-19 2003-09-19 Nanoparticle conjugates and method of production thereof
PCT/GB2004/003986 WO2005029076A2 (en) 2003-09-19 2004-09-20 Nanoparticle conjugates and method of production thereof

Publications (1)

Publication Number Publication Date
AU2004274694A1 true AU2004274694A1 (en) 2005-03-31

Family

ID=29266267

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004274694A Abandoned AU2004274694A1 (en) 2003-09-19 2004-09-20 Nanoparticle conjugates and method of production thereof

Country Status (7)

Country Link
US (1) US20070054337A1 (enExample)
EP (1) EP1664776A2 (enExample)
JP (1) JP2007506084A (enExample)
AU (1) AU2004274694A1 (enExample)
CA (1) CA2539501A1 (enExample)
GB (1) GB0321937D0 (enExample)
WO (1) WO2005029076A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9434770B2 (en) * 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
JP5059312B2 (ja) * 2005-09-16 2012-10-24 Ｈｏｙａ株式会社 高分散性リン酸カルシウム系化合物ナノ粒子及びその製造方法
KR100713745B1 (ko) * 2006-02-27 2007-05-07 연세대학교 산학협력단 상전이 리간드로 코팅된 수용성 자성 또는 금속 산화물나노입자 및 이의 제조방법
KR20090059148A (ko) 2006-09-11 2009-06-10 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 쿠프레독신 유래된 펩티드의 변형 및 이의 이용 방법
JP5746469B2 (ja) 2006-10-04 2015-07-08 ブルックヘブン サイエンス アソシエイツ Ｄｎａによって導かれたナノ粒子凝集
WO2008134586A1 (en) * 2007-04-27 2008-11-06 The Regents Of The University Of California Site-specific conjugation of ligands to nanoparticles
WO2009002837A1 (en) * 2007-06-26 2008-12-31 Massachusetts Institute Of Technology Controlled modification of semiconductor nanocrystals
CN101113457B (zh) * 2007-07-04 2010-05-19 中国科学院长春应用化学研究所 富精氨酸寡肽-金纳米粒子细胞传输载体合成方法
EP2240782A2 (en) * 2008-02-04 2010-10-20 Ulive Enterprises Limited Nanoparticle conjugates
US8729012B2 (en) * 2008-06-02 2014-05-20 Brookhaven Science Associates, Llc Controllable assembly and disassembly of nanoparticle systems via protein and DNA agents
KR101014246B1 (ko) * 2008-07-03 2011-02-16 포항공과대학교 산학협력단 페하 민감성 금속 나노 입자 및 이의 제조 방법.
US20100261185A1 (en) 2009-03-27 2010-10-14 Life Technologies Corporation Labeled enzyme compositions, methods and systems
WO2011011631A2 (en) * 2009-07-22 2011-01-27 Samuel Zalipsky Nucleic acid delivery vehicles
WO2011031478A1 (en) * 2009-08-27 2011-03-17 Brown University Fe3o4-m(au-like)-nanoparticles for antibody-conserving target-specific platin delivery
US8378075B2 (en) * 2009-10-27 2013-02-19 The United States Of America, As Represented By The Secretary Of The Navy Covalent attachment of peptides and biological molecules to luminescent semiconductor nanocrystals
US9114107B2 (en) 2010-10-05 2015-08-25 Drexel University Compositions for inhibiting virus entry and promoting virolysis, and methods thereof
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
DK3489685T3 (da) 2011-11-21 2023-12-04 Zoetis Services Llc Signalforstærkning i sidestrømning og tilsvarende immunoassays
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
GB201209517D0 (en) * 2012-05-29 2012-07-11 Univ Birmingham Nanoparticles
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
CN102896325B (zh) * 2012-10-12 2014-04-16 江南大学 一种基于无机小分子盐的金纳米棒手性自组装材料制备方法
CN103058133B (zh) * 2013-01-30 2014-01-08 江南大学 一种基于非手性小分子组装手性纳米材料的制备方法
US9234078B2 (en) 2013-03-21 2016-01-12 The Regents Of The University Of Michigan Conjugated gold nanoparticles
US9233138B2 (en) 2013-10-22 2016-01-12 Drexel University Compositions for promoting HIV-1 virolysis and methods using same
SG10201912301XA (en) 2013-11-04 2020-02-27 Uti Lp Methods and compositions for sustained immunotherapy
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
US12011480B2 (en) 2015-05-06 2024-06-18 Uti Limited Partnership Nanoparticle compositions for sustained therapy
JP6944438B2 (ja) 2015-08-04 2021-10-06 ゾエティス サービシズ リミテッド ライアビリティ カンパニー 溶液ベースのプラズモン特異的結合パートナーアッセイにおけるシグナル増幅
WO2018094213A1 (en) * 2016-11-18 2018-05-24 Kansas State University Research Foundation Microfluidics-based nanobiosensors and devices
KR102654470B1 (ko) 2017-01-30 2024-04-05 조에티스 서비시즈 엘엘씨 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체
CN111741746A (zh) 2017-11-29 2020-10-02 乌第有限合伙公司 治疗自身免疫性疾病的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121425A (en) * 1994-07-29 2000-09-19 Nanoprobes, Inc. Metal-lipid molecules
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US6086881A (en) * 1998-05-15 2000-07-11 Children's Medical Center Corp. Spatially aligned conjugated composition having a thioether bond linkage
US6953656B2 (en) * 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of polypeptides

Also Published As

Publication number Publication date
US20070054337A1 (en) 2007-03-08
CA2539501A1 (en) 2005-03-31
GB0321937D0 (en) 2003-10-22
JP2007506084A (ja) 2007-03-15
WO2005029076A2 (en) 2005-03-31
EP1664776A2 (en) 2006-06-07
WO2005029076A3 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
US20070054337A1 (en) Nanoparticle conjugates and method of production thereof
US20110165647A1 (en) Nanoparticle conjugates
Gu et al. Biofunctional magnetic nanoparticles for protein separation and pathogen detection
AU2003247788B2 (en) Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
CN102066941B (zh) 用于生物传感器的新型Au/Ag核-壳复合材料
Matsunaga et al. Biotechnological application of nano-scale engineered bacterial magnetic particles
KR101088885B1 (ko) 바이오프로브, 그 제조방법, 상기를 사용한 분석 장치 및 분석 방법
US20080241964A1 (en) Material for improving sensitivity of magnetic sensor and method thereof
US20120202218A1 (en) Detection method and device based on nanoparticle aggregation
KR20040083095A (ko) 페라이트 결합 유기 물질 및 이의 제조 방법
JP2006508095A (ja) 粒子の生物活性化
JP2008268186A (ja) 磁気センサーの感度向上材料及び方法
Liu et al. Nanovehicles based bioassay labels
KR100989289B1 (ko) 자성-표면증강 라만산란 입자, 이의 제조방법, 및 이를 이용한 바이오센서
Cháfer-Pericás et al. Functionalized inorganic nanoparticles used as labels in solid-phase immunoassays
JP4335526B2 (ja) コロイド構造体および非コロイド構造体による結合スピーシーズの検出
Woolley et al. From particle to platelet: optimization of a stable, high brightness fluorescent nanoparticle based cell detection platform
Hainfeld et al. Nanoparticle molecular labels
JP5147452B2 (ja) 磁気バイオセンサーを利用した標的物質検出方法及びキット
JP2010002393A (ja) 標的物質の検出方法
Brayner Current Approaches in Natural BiopolymerNanoparticle Hybrid Functional Materials: From Drug Delivery to Bio-Detection Applications
HK1158309B (en) Novel au / ag core-shell composite useful for biosensor

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application